| scholarly article | Q13442814 |
| P2093 | author name string | R C Langer | |
| M W Riggs | |||
| D A Schaefer | |||
| P2860 | cites work | Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice | Q77957618 |
| The Thrombospondin-related Protein Family of Apicomplexan Parasites: The Gears of the Cell Invasion Machinery | Q79239988 | ||
| Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody | Q24515033 | ||
| In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs | Q28331628 | ||
| Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery. | Q28368293 | ||
| Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models | Q28368312 | ||
| Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes | Q30039117 | ||
| Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family. | Q32064922 | ||
| Adhesive proteins of the malaria parasite | Q33538651 | ||
| Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment | Q33596699 | ||
| Designing blood-stage vaccines against Babesia bovis and B. bigemina | Q33666101 | ||
| Biochemical peculiarities and drug targets in Cryptosporidium parvum: lessons from other coccidian parasites | Q33687965 | ||
| Passive antibody therapies: progress and continuing challenges | Q33738359 | ||
| Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a beta-mannosylated glycolipid | Q34000648 | ||
| Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells | Q34002128 | ||
| Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis | Q34004213 | ||
| The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites | Q34237481 | ||
| A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion | Q34483227 | ||
| Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. | Q34541501 | ||
| Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells. | Q35464922 | ||
| Attachment of Toxoplasma gondii to host cells is host cell cycle dependent | Q35523545 | ||
| Subcellular localization and functional characterization of Nc-p43, a major Neospora caninum tachyzoite surface protein | Q35525730 | ||
| In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies. | Q35555866 | ||
| Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines | Q35559983 | ||
| Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice | Q35780393 | ||
| Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. | Q35781709 | ||
| Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria | Q36200458 | ||
| Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. | Q36362740 | ||
| Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans | Q36367649 | ||
| CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages | Q36367680 | ||
| Improved plaque assays for Rickettsia prowazekii in Vero 76 cells | Q36537072 | ||
| Molecular cloning and characterization of a novel acidic microneme protein (Etmic-2) from the apicomplexan protozoan parasite, Eimeria tenella | Q36825366 | ||
| A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes | Q36829621 | ||
| Analysis of adhesion and cytotoxicity of Tritrichomonas foetus to mammalian cells by use of monoclonal antibodies | Q36952085 | ||
| Sexual stage development of cryptosporidia in the Caco-2 cell line | Q36990496 | ||
| Infectivity and neutralization of Cryptosporidium parvum sporozoites | Q37022387 | ||
| Enteric lesions and diarrhea in gnotobiotic calves monoinfected with Cryptosporidium species | Q38536283 | ||
| Rationale for the development of an engineered sporozoite malaria vaccine | Q38665423 | ||
| Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. | Q39537744 | ||
| Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products | Q39537756 | ||
| Purification and expression of the Tf190 adhesin in Tritrichomonas foetus | Q39570345 | ||
| Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. | Q39572079 | ||
| Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line | Q40149622 | ||
| Antibody-based immunotherapy of cryptosporidiosis | Q40862334 | ||
| Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells | Q40903803 | ||
| Enzyme immunoassay detection of Cryptosporidium parvum inhibition by sinefungin in sporozoite infected HCT-8 enterocytic cells | Q40942214 | ||
| A Toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection | Q40982669 | ||
| Cryptosporidium parvum development in the BS-C-1 cell line. | Q41062412 | ||
| An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum. | Q41114340 | ||
| Simplified methods for obtaining purified oocysts from mice and for growing Cryptosporidium parvum in vitro. | Q41162736 | ||
| Complete development of Cryptosporidium parvum in MDBK cells | Q41175097 | ||
| Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion | Q41232533 | ||
| Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells | Q41354342 | ||
| Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines | Q41468044 | ||
| Cryptosporidium parvum: culture in MDCK cells | Q41569343 | ||
| Cryptosporidium parvum: in vitro cultivation in Madin-Darby canine kidney cells | Q41657948 | ||
| The surface of Toxoplasma: more and less | Q41721903 | ||
| Physiopathologic and therapeutic studies in in vitro and in vivo models of Cryptosporidium parvum infection | Q41723759 | ||
| Cryptosporidium: molecular basis of host-parasite interaction | Q41745364 | ||
| Cryptosporidiosis: laboratory investigations and chemotherapy | Q41745369 | ||
| In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvum | Q42543812 | ||
| Inhibition of complete development of Cryptosporidium parvum in Caco-2 cells | Q42551577 | ||
| Sequence of the gene encoding an immunodominant microneme protein of Eimeria tenella. | Q42619273 | ||
| Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA. | Q43499223 | ||
| Effects of carbohydrates and lectins on cryptosporidial sporozoite penetration of cultured cell monolayers | Q44550826 | ||
| Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein | Q44871427 | ||
| Neutralization-sensitive epitopes are exposed on the surface of infectious Cryptosporidium parvum sporozoites | Q45092425 | ||
| Cultural and Antigenic Properties of Newly Established Cell Strains Derived From Adenocarcinomas of the Human Colon and Rectum | Q47872753 | ||
| A microneme protein from Eimeria tenella with homology to the Apple domains of coagulation factor XI and plasma pre-kallikrein | Q47877521 | ||
| Molecular characterization of a thrombospondin-related anonymous protein homologue in Neospora caninum | Q47877546 | ||
| The major 36 kDa Neospora caninum tachyzoite surface protein is closely related to the major Toxoplasma gondii surface antigen | Q47996653 | ||
| The MIC1 microneme protein of Toxoplasma gondii contains a duplicated receptor-like domain and binds to host cell surface | Q48056588 | ||
| Ultrastructure, fractionation and biochemical analysis of Cryptosporidium parvum sporozoites. | Q52537143 | ||
| Polyoma transformation of hamster cell clones—an investigation of genetic factors affecting cell competence | Q52828028 | ||
| The establishment of strains of human cells in tissue culture. | Q52831945 | ||
| Established kidney cell lines of normal adult bovine and ovine origin. | Q52832897 | ||
| Identification of heparin as a ligand for the A-domain of Plasmodium falciparum thrombospondin-related adhesion protein | Q56837683 | ||
| In vitro multiplication of cryptosporidium parvum in mouse peritoneal macrophages | Q58862600 | ||
| Ultrastructure of the attachment of Cryptosporidium sporozoites to tissue culture cells | Q67973735 | ||
| Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients | Q69029106 | ||
| Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30) | Q72106874 | ||
| Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites | Q73064395 | ||
| Secretion of micronemal proteins is associated with toxoplasma invasion of host cells | Q73510453 | ||
| Sexual and asexual development of Cryptosporidium parvum in five oocyst- or sporozoite-infected human enterocytic cell lines | Q74064362 | ||
| Apical organelles and host-cell invasion by Apicomplexa | Q77184156 | ||
| Phenotypic comparison of ileal intraepithelial lymphocyte populations of suckling and weaned calves | Q77296578 | ||
| Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell | Q77920971 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cryptosporidium parvum | Q134734 |
| P304 | page(s) | 1661-1670 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL | |
| P478 | volume | 69 |
| Q35652353 | Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst |
| Q34750382 | Cryptosporidiosis and the challenges of chemotherapy |
| Q30308822 | Cryptosporidiosis: an update |
| Q34793040 | Cryptosporidiosis: biology, pathogenesis and disease |
| Q38200248 | Cryptosporidium infections: molecular advances |
| Q26823336 | Cryptosporidium pathogenicity and virulence |
| Q34594001 | Cryptosporidium virulence determinants--are we there yet? |
| Q38084328 | Dysfunctions at human intestinal barrier by water-borne protozoan parasites: lessons from cultured human fully differentiated colon cancer cell lines |
| Q34105139 | Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis |
| Q35803331 | Heparin interacts with elongation factor 1α of Cryptosporidium parvum and inhibits invasion |
| Q34835619 | Mechanisms of infectious diarrhea |
| Q36965719 | Microbial adhesion of Cryptosporidium parvum sporozoites: purification of an inhibitory lipid from bovine mucosa. |
| Q36426058 | Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections |
| Q30436681 | Pathophysiology and impact of enteric bacterial and protozoal infections: new approaches to therapy |
| Q45226978 | Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms |
| Q34793048 | Recent advances in cryptosporidiosis: the immune response |
Search more.